OK Biotech Co., Ltd.
Research OK Biotech Co., Ltd. (4155.TW) on Bullrun: market cap TWD 1.86B, P/E 7.5, dividend yield 6.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4155.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyTWD
- Market capTWD 1.86B
- P/E7.5
- Dividend yield6.1%
- Financial periodQ2 2026
- RevenueTWD 436.13M
- Net incomeTWD 48.16M
- Free cash flowTWD 92.40M
- Gross margin29.9%
Valuation Snapshot
latest market cap is TWD 1.86B; P/E is 7.5; dividend yield is 6.1%.
Peer valuation comparison
Latest P/E is 7.51x versus a Healthcare sector median of 21.8x (65.5% below).
Latest dividend yield is 6.14% versus a Healthcare sector median of 2.4% (155.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 1.86B | 7.5 | 1.9% | 0.3 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.3 TWD, yield 6.1%.
About OK Biotech Co., Ltd.
OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services.
ETFs that hold OK Biotech Co., Ltd.
US-listed ETFs
OK Biotech Co., Ltd. is held by 3 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| Avantis Emerging Markets Small Cap Equity ETF (AVEE) | <0.01% | 0.42% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is OK Biotech Co., Ltd.'s market cap?
OK Biotech Co., Ltd.'s market capitalization is TWD 1.86B.
What is OK Biotech Co., Ltd.'s P/E ratio?
OK Biotech Co., Ltd.'s price-to-earnings (P/E) ratio is 7.5.
Does OK Biotech Co., Ltd. pay a dividend?
OK Biotech Co., Ltd. has a dividend yield of 6.1%.
What does OK Biotech Co., Ltd. do?
OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services. The company sells its products under the OKB and Prodigy brands. OK Biotech Co., Ltd.